Abstract
Selective cyclooxygenase 2 (COX 2) inhibitors NS-398 and nimesulide were investigated for their effects on patellar cartilage and bone content in a model of Mycobacterium tuberculosis (M.tb)-induced monoarticular arthritis in the rat. The protective/destructive properties of these nonsteroidal antiinflammatory drugs (NSAIDs) were compared with piroxicam, known to accelerate cartilage breakdown and reduce bone erosion in this model in comparison to untreated arthritic controls. Male CFHB Wistar rats were injected intraarticularly with heat killed M.tb into the left stifle joint, resulting in loss of patellar cartilage glycosaminoglycans (GAG), bone erosion and inflammation. The right stifle joint received saline. Animals were dosed daily, p.o. with NS-398 (1, 10 mg/kg), nimesulide (0.5, 5 mg/kg) or piroxicam (10 mg/kg). Four days after M.tb injection, patellar GAG content, bone weight and joint swelling were measured in drug-treated animals and untreated arthritic controls. Changes in the left joint were compared to the right. The expression and distribution of COX 2 protein was determined by immunocytochemistry in synovial tissue from arthritic controls over the time course. Focal accumulations of inflammatory cells were positively immunolabelled for COX 2 in the synovium from the left stifle joint of untreated arthritic animals, 6 h after injection of M.tb. Labeling of inflammatory cell infiltrates increased and was widespread in the synovium at 24 h. By day 4 fibroblasts were positively labelled for COX 2 in addition to polymorphonuclear and mononuclear leukocytes. Piroxicam and nimesulide at the higher dose significantly exacerbated M.tb-induced cartilage GAG loss while NS-398 was without effect. Both COX 2 inhibitors did not alter M.tb-induced patellar bone loss. In contrast, piroxicam significantly reduced bone loss. All COX inhibitors significantly reduced joint swelling. In conclusion, the selective inhibition of COX 2 may result in the amelioration of synovitis with a lowered risk of NSAID-induced cartilage damage in rheumatic disease.
Similar content being viewed by others
REFERENCES
Henderson, B. and E. R. Pettipher. 1985. The synovial lining cell: biology and pathobiology. Semin. Arthritis Rheum. 15:1–32.
Xie, W. L., J. G. Chipmam, D. L. Robertson, R. L. Erikson, and D. L. Simmons. 1991. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc. Natl. Acad. Sci. U.S.A. 88:2692–2696.
Kujubu, D. A., B. S. Fletcher, B. C. Varnum, R. W. Lim, and H. R. Herschman. 1991. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J. Biol. Chem. 266:12866–12872.
Vane, J. R., J. A. Mitchell, I. Appleton, A. Tomlinson, D. Bishop-Bailey, J. Croxtall, and D. A. Willoughby. 1994. Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc. Natl. Acad. Sci. U.S.A. 91:2046–2050.
Tomlinson, A., I. Appleton, A. R. Moore, D. W. Gilroy, D. Willis, J. A. Mitchell, and D. A. Willoughby. 1994. Cyclo-oxygenase and nitric oxide synthase isoforms in rat carrageenin-induced pleurisy. Br. J. Pharmacol. 113:693–698.
Anderson, G. D., S. D. Hauser, K. L. McGarity, M. E. Bremer, P. C. Isakson, and S. A. Gregory. 1996. Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis. J. Clin. Invest. 97:2672–2679.
Crofford, L. J., R. L. Wilder, A. P. Ristimaki, H. Sano, E. F. Remmers, H. R. Epps, and T. Hla. 1994. Cyclooxygenase-1 and-2 expression in rheumatoid synovial tissues. Effects of interleukin-1 beta, phorbol ester, and corticosteroids. J. Clin. Invest. 93:1095–1101.
Vane, J. R. 1971. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat. New Biol. 231:232–235.
Pettipher, E. R., B. Henderson, J. C. Edwards, and G. A. Higgs. 1989. Effects of indomethacin on swelling, lymphocyte influx and cartilage proteoglycan depletion in experimental arthritis. Ann. Rheum. Dis. 48:623–627.
Brandt, K. D. 1987. Effects of nonsteroidal anti-inflammatory drugs on chondrocyte metabolism in vitro and in vivo. Am. J. Med. 83:29–34.
Bottomley, K. M. K., R. J. Griffiths, T. J. Rising, and A. Steward. 1986. A modified mouse air pouch model for evaluating the effects of compounds on granuloma-induced cartilage degradation. British Journal of Pharmacology 93:627–635.
Brandt, K. D. 1987. Nonsteroidal antiinflammatory drugs and articular cartilage. J. Rheumatol. 14:132–133.
Bulstra, S. K., R. Kuijer, W. A. Buurman, E. Terwindt-Rouwenhorst, P. J. Guelen, and A. J. van der Linden. 1992. The effect of piroxicam on the metabolism of isolated human chondrocytes. Clin. Orthop. 277:289–296.
Mitchell, J. A., P. Akarasereenont, C. Thiemermann, C. R. J. Flower, and J. R. Vane. 1993. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc. Natl. Acad. Sci. U.S.A. 90:11693–11697.
Bateman, D. N. 1994. NSAIDs: time to re-evaluate gut toxicity [comment]. Lancet 343:1051–1052.
Seed, M. P., F. L. Parker, S. Johns, A. P. Curnock, A. Bowden, and C. R. Gardner. 1991. Mycobacterium tuberculosis—induced monoarticular arthritis in the rat, a new in vivo model for the assessment of anti-rheumatic drugs. Clinical Rheumatology 10:461–462.
Futaki, N., K. Yoshikawa, Y. Hamasaka, I. Arai, S. Higuchi, H. Iizuka, and S. Ootomo. 1993. NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesions. Gen. Pharmacol. 24:105–110.
Grossman, C. J., J. Wiseman, F. S. Lucas, M. A. Trevethick, and P. J. Birch. 1995. Inhibition of inducible and constitutive cyclooxygenase activity in human platelets and mononuclear cells by NSAIDs and COX 2 inhibitors. Inflammation Research 44:253–257.
Seed, M. P., A. R. Bowden, F. P. Parker, S. Johns, A. Curnock, and C. R. Gardner. 1995. Chondroneutral and chondrotoxic diversity of nonsteroidal antiinflammatory drugs. Br. J. Rheum. 34:15.
Seed, M. P., P. H. Hambleton, A. R. Bowden, S. C. J. Clements-Jewery, and C. R. Gardner. 1993. Rapid quantitation of joint destruction in irritant monoarticular arthritis induced by heat killed Mycobacterium tuberculosis. European Journal of Rheumatology and Inflammation 13:27–33.
Farndale, R. W., D. J. Buttle, and A. J. Barret. 1986. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethyl blue. Biochem. Biophys. Acta. 883:173–177.
Masferrer, J. L., B. S. Zweifel, P. T. Manning, P. T. Hauser, K. M. Leahy, W. G. Smith, P. C. Isakson, and K. Seibert. 1994. Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and non-ulcerogenic. Proc. Natl. Acad. Sci. U.S.A. 91:3228–3232.
Harada, Y., K. Hatanaka, M. Kawamura, M. Saito, M. Ogino, M. Majima, T. Ohno, K. Ogino, K. Yamamoto, Y. Taketani, S. Yamamoto, and M. Katori. 1996. Role of prostaglandin H synthase-2 in prostaglandin E2 formation in rat carrageenin-induced pleurisy. Prostaglandins 51:19–33.
Magni, E. 1993. The effect of nimesulide on prostanoid formation. Drugs 46:10–14.
Dingle, J. T., and M. J. Shield. 1990. The interactions of cytokines, NSAIDs and prostaglandins in cartilage destruction and repair. Advances in Prostaglandin, Thromboxane and Leukotriene Research 21:955–966.
Newman, N. M. and R. S. Ling. 1985. Acetabular bone destruction related to nonsteroidal anti-inflammatory drugs. Lancet 2:11–14.
Mizel, S. B., J. M. Dayer, S. M. Krane, and S. E. Mergenhagen. 1981. Stimulation of rheumatoid cell collagenase and prostaglandin production by partially purified lymphocyte activation factor (interleukin-1). Proc. Natl. Acad. Sci. U.S.A. 78:2474–2477.
Kunkel, S. L., S. W. Chemsue, and S. H. Phan. 1986. Prostaglandins as endogenous mediators of interleukin production. J. Immunol. 136:186–192.
Mertz, P. M., D. L. DeWitt, W. G. Stetler-Stevenson, and L. M. Wahl. 1994. Interleukin 10 suppression of monocyte prostaglandin H synthase-2. Mechanism of inhibition of protaglandin-dependent matrix metalloproteinase production. J. Biol. Chem. 269:21322–21329.
Adolphson, P., H. Abbaszadegan, U. Jonsson, N. Dalen, H. E. Sjoberg, and S. Kalen. 1993. No effects of piroxicam on osteopenia and recovery after Colles' fracture. A randomized, double-blind, placebo-controlled, prospective trial. Arch. Orthop. Trauma Surg. 112:127–130.
Adolphson, P., U. Jonsson, and N. Dalen, N. 1991. Piroxicam-induced reduction in osteopenia after external fixation of rabbit tibia. Acta. Orthop. Scand. 62:363–366.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gilroy, D.W., Tomlinson, A., Greenslade, K. et al. The Effects of Cyclooxygenase 2 Inhibitors on Cartilage Erosion and Bone Loss in a Model of Mycobacterium tuberculosis-Induced Monoarticular Arthritis in the Rat. Inflammation 22, 509–519 (1998). https://doi.org/10.1023/A:1022350111213
Issue Date:
DOI: https://doi.org/10.1023/A:1022350111213